schizandrin b has been researched along with Cirrhosis, Liver in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Hua, M; Li, Z; Sun, Y; Xia, Y; Zhao, L | 1 |
| Chen, L; Ding, T; Jin, H; Ma, M; Song, A; Wei, N; Yang, J; Zheng, S | 1 |
| Chao, X; Cuiqiong, W; Xinling, F; Yinyan, J | 1 |
| Lam, HYP; Liang, TR; Peng, SY | 1 |
| Cao, Y; Chen, Q; Li, Y; Sun, S; Zhang, G; Zhang, H; Zhang, J | 1 |
| Chen, Q; Dahan, A; Tan, W; Wei, L; Xue, J; Zhang, G; Zhang, H | 1 |
| Chan, CL; Chao, X; Dai, W; Fong, WF; Fu, X; Kwan, HY; Lee, KC; Li, T; Lu, A; Niu, X; Pan, SY; Su, T; Tong, T; Tse, AK; Yi, H; Yu, H; Yu, ZL | 1 |
| Liu, CH; Liu, S; Tao, YY; Yang, T; Zheng, TH | 1 |
8 other study(ies) available for schizandrin b and Cirrhosis, Liver
| Article | Year |
|---|---|
Schisandrin B Attenuates Hepatic Stellate Cell Activation and Promotes Apoptosis to Protect against Liver Fibrosis.
Topics: Animals; Antifibrotic Agents; Apoptosis; Cell Line; Cyclooctanes; Hepatic Stellate Cells; Humans; Lignans; Liver Cirrhosis; Polycyclic Compounds; Protective Agents; Rats | 2021 |
Schisandrin B promotes senescence of activated hepatic stellate cell via NCOA4-mediated ferritinophagy.
Topics: Animals; Cellular Senescence; Hepatic Stellate Cells; Liver Cirrhosis; Mice; Mice, Inbred ICR; Nuclear Receptor Coactivators; RNA, Small Interfering; Transcription Factors; Tumor Suppressor Protein p53 | 2023 |
Schisandrin B suppresses liver fibrosis in rats by targeting miR-101-5p through the TGF-β signaling pathway.
Topics: Animals; Carbon Tetrachloride Poisoning; Cyclooctanes; Humans; Lignans; Liver Cirrhosis; Male; MicroRNAs; Polycyclic Compounds; Rats; Rats, Sprague-Dawley; Signal Transduction; Transforming Growth Factor beta | 2020 |
Ameliorative effects of Schisandrin B on Schistosoma mansoni-induced hepatic fibrosis in vivo.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Cyclooctanes; Inflammasomes; Lignans; Liver Cirrhosis; Male; Mice; Mice, Inbred BALB C; Polycyclic Compounds; RAW 264.7 Cells; Schistosoma mansoni; Schistosomiasis mansoni; Spleen | 2021 |
Schisandrin B attenuates CCl
Topics: Animals; Carbon Tetrachloride; Cyclooctanes; Lignans; Liver Cirrhosis; Male; Molecular Structure; NF-E2-Related Factor 2; Polycyclic Compounds; Rats; Rats, Wistar; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2017 |
Transcriptomic analyses reveal the molecular mechanisms of schisandrin B alleviates CCl
Topics: Animals; Apoptosis; Carbon Tetrachloride; Cyclooctanes; Down-Regulation; Endoplasmic Reticulum Stress; Gene Expression Profiling; Lignans; Liver; Liver Cirrhosis; Male; Medicine, Chinese Traditional; Polycyclic Compounds; Rats; Rats, Wistar; RNA; Schisandra; Sequence Analysis, RNA; Signal Transduction; Transcriptome; Up-Regulation | 2019 |
Lipidomic-based investigation into the regulatory effect of Schisandrin B on palmitic acid level in non-alcoholic steatotic livers.
Topics: Animals; Cyclooctanes; Diet, High-Fat; Disease Models, Animal; Fasting; Fatty Acid Synthases; Fatty Acids; Lignans; Lipid Metabolism; Lipids; Lipolysis; Liver; Liver Cirrhosis; Male; Metabolic Networks and Pathways; Metabolomics; Mice; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Palmitic Acid; Polycyclic Compounds; Sterol Regulatory Element Binding Protein 1; Tumor Necrosis Factor-alpha | 2015 |
Comparative pharmacokinetics and tissue distribution profiles of lignan components in normal and hepatic fibrosis rats after oral administration of Fuzheng Huayu recipe.
Topics: Administration, Oral; Animals; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Kidney; Lignans; Liver; Liver Cirrhosis; Male; Polycyclic Compounds; Rats; Rats, Wistar; Tissue Distribution | 2015 |